BRIEF RESEARCH REPORT article
Front. Psychiatry
Sec. Mood Disorders
The Bipolar Disorder Medication Adherence Battery (BD-MAB): Validity, Reliability, and Clinical Benchmarks
Provisionally accepted
- 1Isik University, Istanbul, Türkiye
- 2Istanbul Universitesi, Fatih, Türkiye
- 3Istanbul Bakirkoy Prof Dr Mazhar Osman Ruh Sagligi ve Sinir Hastaliklari Egitim ve Arastirma Hastanesi, Istanbul, Türkiye
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Medication adherence is pivotal in bipolar disorder, yet no tools assess the full range of psychological and contextual determinants that translate intention into behavior. This study developed and validated the Bipolar Disorder Medication Adherence Battery (BD-MAB) to support routine, measurement-based care. Methods: Guided by the Integrated Behavioral Model, we mapped process measures—Attitude; Perceived norms (supportive, oppositional, pressuring, descriptive); Perceived control; Self-efficacy; Knowledge and skills; Environmental Constraints; Salience of Behavior; Habit; Intention and a behavior indicator. Psychometrics included internal consistency; construct validity via inter-construct correlations; convergent and discriminant validity with the Medication Adherence Rating Scale, Medication Adherence Report Scale, perceived social support, and quality of life; criterion validity against same-day serum medication levels; and distribution-based thresholds (standard error of measurement, critical change, minimally important difference, reliable change index). Results: Administered to euthymic adults with bipolar I disorder receiving mood stabilizers at a tertiary psychiatric hospital, the BD-MAB showed acceptable to excellent internal consistency across multi-item scales. Relations among constructs were theory-consistent, with intention aligning most closely with self-efficacy and attitudes, and the behavior indicator tracking intention. Concordance with serum levels supported criterion validity, and associations with an established adherence measure supported convergent validity. Clinically interpretable thresholds were derived to flag meaningful change for use in routine care. Conclusions: The BD-MAB offers a comprehensive, clinically actionable assessment of adherence determinants and behavior in bipolar disorder, with initial evidence for reliability, validity, and practical change metrics to guide patient-level monitoring.
Keywords: adherence, Bipolar Disorder, Compliance, evidence-based assessment, scale validation
Received: 23 Oct 2025; Accepted: 29 Dec 2025.
Copyright: © 2025 Ünver, Sertel Berk and Karamustafalıoğlu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Buket Ünver
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.